Inventor
JULIE L. ENGERS
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes27%
C07BGeneral methods of organic chemistry13%
PatentTitleYear
12,577,234Antagonists of the muscarinic acetylcholine receptor M4202612,139,498Positive allosteric modulators of the muscarinic acetylcholine receptor M4202411,851,406Positive allosteric modulators of the muscarinic acetylcholine receptor M202311,820,757Antagonists of the muscarinic acetylcholine receptor M202311,414,406Antagonists of the muscarinic acetylcholine receptor M202211,376,254Positive allosteric modulators of the muscarinic acetylcholine receptor M4202211,299,481Antagonists of the muscarinic acetylcholine receptor M4202211,149,022Antagonists of the muscarinic acetylcholine receptor M4202111,142,532Positive allosteric modulators of the muscarinic acetylcholine receptor M42021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to UNIV VANDERBILT (9)· patent assignee history
2021–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV VANDERBILT | 9 | 2021–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2021–2026 |